Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP4 | P15090 | 2/20 | 0.37 |
| ▸ | FABP3 | P05413 | 1/20 | 0.37 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | APEX1 | P27695 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | CA5A | P35218 | 1/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28147772 | 0.90 | FABP4 (0.36) | FABP4FABP3FABP5KDM4EPOLB | |
| SCHEMBL83879 | 0.87 | FABP4 (0.36) | FABP4FABP3FABP5KDM4EPOLB | |
| SCHEMBL2862401 | 0.86 | FABP4 (0.37) | FABP4FABP3FABP5KDM4EPOLB | |
| SCHEMBL2869222 | 0.83 | FABP4 (0.38) | FABP4FABP3FABP5KDM4EPOLB | |
| SCHEMBL20025727 | 0.82 | FABP3 (0.37) | FABP4FABP3FABP5KDM4EPOLB | |
| Ammonia Solution, Strong SCHEMBL9809148 | 0.80 | FABP4 (0.36) | FABP4FABP3FABP5KDM4EPOLB | |
| Hydrochloric Acid SCHEMBL11010689 | 0.80 | FABP4 (0.36) | FABP4FABP3FABP5KDM4EPOLB | |
| SCHEMBL9404146 | 0.80 | FABP3 (0.31) | FABP4FABP3FABP5 | |
| SCHEMBL2869064 | 0.80 | CA1 (0.41) | FABP4FABP3FABP5KDM4EPOLB | |
| SCHEMBL863101 | 0.78 | FABP3 (0.34) | FABP4FABP3FABP5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6670474-B2 | Such as bis-1,2-(2-(2,3-epoxypropyl)phenoxy)ethane; chemical intermediates for formation of epoxy resins | PEWS R GARTH (US) | 2003-12-30 | — | — | US | claimed |
| US-20020151731-A1 | Novel epoxide derivatives of allylarylphenols | PEWS R GARTH (US) | 2002-10-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020151731-A1 | Novel epoxide derivatives of allylarylphenols | EPHX2, CBR3, CYP4X1 | FABP4 1450/4885FABP3 3347/4885FABP5 1221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.